SecBot SecBot
Insider Cluster (4 insiders) ·Filed Aug 14, 2026

TWST

Twist Bioscience Corp
NEUTRAL
Impact 4/10
Horizondays Processed3mo ago
Insider cluster: 4 insiders, $6.4M total
Actionable Insight • Neutral

The insider sell cluster is small relative to market cap and follows a strong earnings report, likely routine option exercises and diversification, not a bearish signal. CEO's cashless exercise pattern (same-day sale of exercised shares) is standard for tax coverage. Monitor for any follow-on SC13D activist filing or next 10-K for unexpected risk disclosures, but this cluster alone does not warrant action.

DirectionNeutral
Confidencemedium
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$124.41
T+0 close · Aug 14, 2026 · via day close
Latest settled
+6.21%
T+60 · $132.13
Vs SPY
+9.15%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 17 $124.41entry
  2. T+1 · 3mo ago −6.68%α −6.00% · $116.10
  3. T+5 · 3mo ago +13.17%α +14.36% · $140.80
  4. T+20 · 2mo ago +11.00%α +12.98% · $138.10
  5. T+60 · 6d ago +6.21%α +9.15% · $132.13
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Multiple Twist Bioscience insiders, including CEO Emily Leproust, sold a combined $6.37M of stock over a 7-day window. The CEO's sales were part of a same-day cashless exercise of 19,952 options, while Director Robert Chess sold $2M and Dennis Cho sold $1.56M. These sales come 12 days after a strong Q3 earnings beat and raised guidance, likely representing routine portfolio diversification following a significant stock run-up.

Key Financial Metrics

Direction
selling
Total Value
$6.4M
Insiders
4

Key Facts

  • Total insider sales of $6.37M over 7-day window
  • CEO Leproust sold 19,952 shares for $2.50M as part of a same-day option exercise (cashless)
  • Director Robert Chess sold 18,400 shares for $2.04M
  • See Remarks executive Dennis Cho sold 14,200 shares for $1.56M
  • Sales occurred 12 days after Q3 FY2026 earnings beat ($118.4M vs $114.5M consensus) and guidance raise
  • Cluster is predominantly sell-side; no open-market purchases in the window
  • Total sales represent ~0.08% of Twist's $7.9B market cap
  • Recent 30-day insider activity shows 4 sells totaling $19.0M prior to this cluster

Financial Impact

Insider selling cluster of $6.37M represents approximately 0.08% of Twist's $7.9B market cap, well below the 0.1% materiality threshold. No evidence of panic selling or broad-based insider exodus.

Risk Factors

  • CEO sold 100% of her exercise-day shares, a modest concern if this becomes a regular pattern
  • Director Chess's $2M sale is the largest non-CEO transaction and could indicate some board-level selling pressure
  • No insider buying anywhere in the cluster to offset the sell signal

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
94% bullish (16 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-TWST-1786775003123

US Market Status

Market Closed · Opens Tue (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 15, 2026